The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Comparison of treatment discontinuation rates between CDK4/6 inhibitors.
 
Maya Kosaka
No Relationships to Disclose
 
Maki Tanioka
No Relationships to Disclose
 
Takuya Nishina
No Relationships to Disclose
 
Kenji Takata
No Relationships to Disclose
 
Otsuka Shoko
No Relationships to Disclose
 
Takahiro Tsukioki
No Relationships to Disclose
 
Yuko Takahashi
Research Funding - MSD
 
Tsuguo Iwatani
No Relationships to Disclose
 
Kensuke Kawasaki
No Relationships to Disclose
 
Tadahiko Shien
Consulting or Advisory Role - Allergan; AstraZeneca; Chugai Pharma; Daiichi Sankyo; Eisai; Kyowa Kirin; Lilly; Novartis; Pfizer; Taiho Pharmaceutical; Takeda
Speakers' Bureau - Allergan; AstraZeneca; Chugai Pharma; Daiichi Sankyo; Eisai; Kyowa Kirin; Lilly; Nihonkayaku; Novartis; Pfizer; Taiho Pharmaceutical; Takeda
Research Funding - Eisai (Inst); Nihonkayaku (Inst)